DUX4 and acute lymphoblastic leukemia: To characterize further the mutational landscape of DUX4-rearranged BCP ALL, whole-exome sequencing (WES) was performed in five DUX4-rearranged cases with matched constitutional samples available (Supplementary Data 6).